IAN F SMITH Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for IAN F SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of IAN F SMITH. IAN F SMITH is EVP & CFO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, CFO & COO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, COO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP & CFO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in ACORDA THERAPEUTICS INC ($ACOR) and Director in Ophthotech Corp. ($OPHT) and Director in Solid Biosciences Inc. ($SLDB) and in Foghorn Therapeutics Inc. ($FHTX).
IAN F SMITH in VERTEX PHARMACEUTICALS INC / MA
Trading Symbol: VRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of IAN F SMITH: EVP, COO, EVP, CFO & COO, EVP & CFO, SVP & CFO
Holdings: 70,074 shares
Current Value: $6,085,226
Latest Transaction: Jul 03 2018
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of IAN F SMITH in VERTEX PHARMACEUTICALS INC / MA
Sentiment: All, ACOR, FHTX, INFI, OPHT, SLDB, VRTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 22 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.64 | 93 | 2,571 | 84,487 | 84.6 K to 84.5 K (-0.11 %) |
May 22 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.54 | 93 | 2,561 | 84,580 | 84.7 K to 84.6 K (-0.11 %) |
May 22 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.47 | 93 | 2,555 | 84,673 | 84.8 K to 84.7 K (-0.11 %) |
May 22 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.71 | 93 | 2,577 | 84,766 | 84.9 K to 84.8 K (-0.11 %) |
May 22 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.61 | 186 | 5,135 | 84,859 | 85 K to 84.9 K (-0.22 %) |
May 22 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.59 | 93 | 2,566 | 85,045 | 85.1 K to 85 K (-0.11 %) |
May 22 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.48 | 93 | 2,556 | 85,138 | 85.2 K to 85.1 K (-0.11 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.41 | 500 | 13,705 | 84,301 | 84.8 K to 84.3 K (-0.59 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.19 | 322 | 8,755 | 84,801 | 85.1 K to 84.8 K (-0.38 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.16 | 200 | 5,432 | 85,123 | 85.3 K to 85.1 K (-0.23 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.15 | 500 | 13,575 | 85,323 | 85.8 K to 85.3 K (-0.58 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.10 | 300 | 8,130 | 85,823 | 86.1 K to 85.8 K (-0.35 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.10 | 478 | 12,954 | 86,123 | 86.6 K to 86.1 K (-0.55 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.09 | 300 | 8,127 | 86,601 | 86.9 K to 86.6 K (-0.35 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.05 | 500 | 13,525 | 86,901 | 87.4 K to 86.9 K (-0.57 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.04 | 400 | 10,816 | 87,401 | 87.8 K to 87.4 K (-0.46 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.02 | 200 | 5,404 | 87,801 | 88 K to 87.8 K (-0.23 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.01 | 400 | 10,804 | 88,001 | 88.4 K to 88 K (-0.45 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.70 | 80 | 2,216 | 88,401 | 88.5 K to 88.4 K (-0.09 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.46 | 100 | 2,746 | 88,481 | 88.6 K to 88.5 K (-0.11 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.26 | 50 | 1,363 | 88,581 | 88.6 K to 88.6 K (-0.06 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.20 | 70 | 1,904 | 88,631 | 88.7 K to 88.6 K (-0.08 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.11 | 580 | 15,724 | 88,701 | 89.3 K to 88.7 K (-0.65 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.07 | 150 | 4,061 | 89,281 | 89.4 K to 89.3 K (-0.17 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.03 | 75 | 2,027 | 89,431 | 89.5 K to 89.4 K (-0.08 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 27.00 | 475 | 12,825 | 89,506 | 90 K to 89.5 K (-0.53 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 26.99 | 50 | 1,350 | 89,981 | 90 K to 90 K (-0.06 %) |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 18.93 | 36,250 | 686,213 | 36,250 | |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 9,667 | 97 | 90,031 | 80.4 K to 90 K (+12.03 %) |
Sep 06 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | M | 26.20 | 90,925 | 2,382,235 | 0 | |
Sep 06 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 40.00 | 90,925 | 3,637,000 | 80,114 | 171 K to 80.1 K (-53.16 %) |
Sep 06 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 26.20 | 90,925 | 2,382,235 | 171,039 | 80.1 K to 171 K (+113.49 %) |
Jul 16 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 28.84 | 36,250 | 1,045,450 | 36,250 | |
May 21 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 31.95 | 823 | 26,295 | 80,114 | 80.9 K to 80.1 K (-1.02 %) |
May 08 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 30.61 | 32,500 | 994,825 | 80,114 | 112.6 K to 80.1 K (-28.86 %) |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 36.30 | 54,375 | 1,973,813 | 54,375 | |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 20,000 | 200 | 112,614 | 92.6 K to 112.6 K (+21.60 %) |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 12,084 | 121 | 92,614 | 80.5 K to 92.6 K (+15.01 %) |
Dec 14 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 38.55 | 480 | 18,504 | 80,530 | 81 K to 80.5 K (-0.59 %) |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | M | 15.60 | 2,213 | 34,523 | 337,385 | |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | M | 15.87 | 1,607 | 25,503 | 339,598 | |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 33.65 | 3,820 | 128,543 | 81,010 | 84.8 K to 81 K (-4.50 %) |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.60 | 2,213 | 34,523 | 84,830 | 82.6 K to 84.8 K (+2.68 %) |
Oct 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.87 | 1,607 | 25,503 | 82,617 | 81 K to 82.6 K (+1.98 %) |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | M | 15.60 | 2,213 | 34,523 | 341,205 | |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | M | 15.87 | 1,607 | 25,503 | 343,418 | |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 34.96 | 3,820 | 133,547 | 81,010 | 84.8 K to 81 K (-4.50 %) |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.60 | 2,213 | 34,523 | 84,830 | 82.6 K to 84.8 K (+2.68 %) |
Jul 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.87 | 1,607 | 25,503 | 82,617 | 81 K to 82.6 K (+1.98 %) |
Jul 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 35.35 | 36,250 | 1,281,438 | 345,025 | |
May 18 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 31.47 | 1,965 | 61,839 | 81,010 | 83 K to 81 K (-2.37 %) |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 15.60 | 2,213 | 34,523 | 308,775 | |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 15.87 | 1,607 | 25,503 | 310,988 | |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 38.31 | 2,213 | 84,780 | 81,010 | 83.2 K to 81 K (-2.66 %) |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.60 | 2,213 | 34,523 | 83,223 | 81 K to 83.2 K (+2.73 %) |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 38.31 | 1,607 | 61,564 | 81,010 | 82.6 K to 81 K (-1.95 %) |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.87 | 1,607 | 25,503 | 82,617 | 81 K to 82.6 K (+1.98 %) |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 15.60 | 6,086 | 94,942 | 312,595 | |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 15.87 | 5,222 | 82,873 | 318,681 | |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 37.81 | 6,086 | 230,112 | 81,010 | 87.1 K to 81 K (-6.99 %) |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.60 | 6,086 | 94,942 | 87,096 | 81 K to 87.1 K (+7.51 %) |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 37.81 | 5,222 | 197,444 | 81,010 | 86.2 K to 81 K (-6.06 %) |
Mar 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.87 | 5,222 | 82,873 | 86,232 | 81 K to 86.2 K (+6.45 %) |
Mar 21 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 40.12 | 1,440 | 57,773 | 81,010 | 82.5 K to 81 K (-1.75 %) |
Feb 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 15.60 | 6,084 | 94,910 | 323,903 | |
Feb 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 15.87 | 5,222 | 82,873 | 329,987 | |
Feb 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 37.77 | 6,084 | 229,793 | 82,450 | 88.5 K to 82.5 K (-6.87 %) |
Feb 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.60 | 6,084 | 94,910 | 88,534 | 82.5 K to 88.5 K (+7.38 %) |
Feb 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 37.77 | 5,222 | 197,235 | 82,450 | 87.7 K to 82.5 K (-5.96 %) |
Feb 23 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Buy | M | 15.87 | 5,222 | 82,873 | 87,672 | 82.5 K to 87.7 K (+6.33 %) |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 35.64 | 73,500 | 2,619,540 | 335,209 | |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 12,200 | 122 | 82,450 | 70.3 K to 82.5 K (+17.37 %) |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Option Exercise | A | 15.60 | 14,381 | 224,344 | 261,709 | |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Option Exercise | A | 15.87 | 12,051 | 191,249 | 276,090 | |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Sell | S | 33.64 | 14,381 | 483,777 | 70,250 | 84.6 K to 70.3 K (-16.99 %) |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Buy | M | 15.60 | 14,381 | 224,344 | 84,631 | 70.3 K to 84.6 K (+20.47 %) |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Sell | S | 33.64 | 12,051 | 405,396 | 70,250 | 82.3 K to 70.3 K (-14.64 %) |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Buy | M | 15.87 | 12,051 | 191,249 | 82,301 | 70.3 K to 82.3 K (+17.15 %) |
Dec 20 2005 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Sell | S | 27.66 | 2,337 | 64,641 | 70,250 | 72.6 K to 70.3 K (-3.22 %) |
Dec 20 2005 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Sell | S | 27.64 | 9,474 | 261,861 | 72,587 | 82.1 K to 72.6 K (-11.55 %) |
Jul 22 2005 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Option Exercise | A | 17.16 | 18,000 | 308,880 | 288,141 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Option Exercise | A | 10.41 | 24,750 | 257,648 | 270,141 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Grant | A | 0.01 | 5,700 | 57 | 75,500 | 69.8 K to 75.5 K (+8.17 %) |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Option Exercise | A | 10.41 | 24,750 | 257,648 | 270,141 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Grant | A | 0.01 | 5,700 | 57 | 75,500 | 69.8 K to 75.5 K (+8.17 %) |
Oct 12 2004 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Option Exercise | A | 11.27 | 18,000 | 202,860 | 245,391 | |
May 10 2004 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Grant | A | 0.01 | 65,000 | 650 | 69,800 | 4.8 K to 69.8 K (+1,354.17 %) |
Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Option Exercise | A | 9.69 | 21,600 | 209,304 | 227,391 | |
Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | SVP & CFO | Grant | A | 0.01 | 2,880 | 29 | 4,800 | 1.9 K to 4.8 K (+150.00 %) |